Every Form 4 that Acacia Resh Corp (ACTG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ACTG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ACTG filings page.
ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling a total of 33,000 shares of ACTG common stock in open market or private transactions. On September 2, 2026, she sold 20,534 shares at a weighted average price of $4.63 per share, in multiple trades between $4.615 and $4.645. On September 3, 2026, she sold 12,466 shares at a weighted average price of $4.57 per share, in multiple trades between $4.51 and $4.66. No Rule 10b5-1 trading plan is reported, and post-transaction share holdings are not stated.
ACACIA RESEARCH CORP (ACTG) director Michelle Felman reported two bona fide gift transactions of ACTG common stock on August 28, 2026. In total, she gifted 32,172 shares, at a reported reference value of $4.49 per share, to an irrevocable trust established for the benefit of her son, for no consideration.
ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling 10,000 shares of ACTG common stock on 2026-08-19 in an open-market transaction. The weighted average sale price was $4.60 per share, with individual trades between $4.57 and $4.63. Following this sale, she directly holds 287,655 shares of ACTG common stock.
Acacia Research Corp director Isaac T. Kohlberg reported an open-market sale of 32,188 shares of ACTG common stock on 2026-08-12. The shares were sold at a weighted average price of $4.67 per share, with individual trades executed between $4.66 and $4.69. Following this transaction, Kohlberg directly holds 78,310 ACTG shares. The filing does not indicate that the sale was made under a Rule 10b5-1 trading plan.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received 6,438 shares of common stock on June 30, 2026, as a grant in lieu of cash for Q2 2026 director fees. The grant was priced at $4.66 per share and increased his direct holdings to 205,966 shares of common stock. This was a compensation-related share award rather than an open-market purchase or sale.
Sundar Ajay reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP insider Ajay Sundar reported receiving a grant of 4,175 shares of Common Stock at $4.79 per share as Q2 2026 director fees paid in stock instead of cash. Following this award, he directly holds 107,605 shares. As of June 23, 2026, he ceased to be a director of the company.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research Corp director Gavin Molinelli received a new equity award. He was granted 25,052 shares of common stock as restricted stock on June 23, 2026, at no purchase price, as part of the company’s annual equity awards to non-employee directors under the 2024 Stock Incentive Plan.
The filing states that 100% of this restricted stock will vest on the first anniversary of the grant date. After this award, Molinelli directly holds 199,528 shares of Acacia Research common stock, reflecting ongoing stock-based compensation rather than an open-market purchase.
Kohlberg Isaac T. reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research Corp director Isaac T. Kohlberg received a grant of 25,052 shares of ACTG common stock as restricted stock. The award was granted on June 23, 2026 as part of the company’s annual equity awards to non-employee directors under the 2024 Stock Incentive Plan.
All of the restricted stock will vest on the first anniversary of the grant date, meaning the shares become fully owned at that time if conditions are met. Following this grant, Kohlberg directly holds a total of 110,498 shares of Acacia Research common stock as reported in the filing.
OCONNELL MAUREEN reported acquisition or exercise transactions in this Form 4 filing.
Acacia Research director Maureen O’Connell reported an equity grant of company stock. On June 23, 2026 she received 25,052 shares of Acacia Research common stock as restricted stock, awarded as part of the company’s annual equity grants to non-employee directors under the 2024 Stock Incentive Plan.
The restricted stock will vest 100% on the first anniversary of the grant date. Following this award, O’Connell directly holds 297,655 shares of Acacia Research common stock. The grant carries no cash purchase price and reflects compensation rather than an open-market trade.
FELMAN MICHELLE reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Michelle Felman reported an equity grant of company stock. On June 23, 2026, she received 25,052 shares of ACTG common stock at no cash cost as a grant or award, increasing her direct holdings to 57,224 shares.
The award is restricted stock granted as part of the company’s annual equity program for non-employee directors under the 2024 Acacia Research Corporation Stock Incentive Plan. According to the terms, 100% of the restricted stock will vest on the first anniversary of the grant date.
Acacia Research Corp General Counsel Jason W. Soncini reported equity compensation activity involving ACTG common stock. On June 5, 2026, he acquired 93,049 shares at $0.00 per share as a grant or award, increasing his direct holdings at that time to 284,600 shares.
On June 8, 2026, 48,985 shares were disposed of at $4.62 per share to satisfy tax withholding obligations related to equity vesting, a non‑market tax-withholding disposition rather than an open-market sale. After these transactions, he directly owned 235,615 ACTG shares.
Footnotes explain that these awards trace back to performance-based restricted stock units granted on June 7, 2023, tied to the company’s compound annual growth rate of adjusted book value per share. On June 5, 2026, the Compensation Committee certified the number of units earned based on achievement of this performance goal, with 121,550 restricted shares vesting on June 7, 2026.
Acacia Research Chief Administrative Officer Robert Rasamny reported equity compensation activity involving ACTG Common Stock. On June 5, 2026, he acquired 60,285 shares at $0.00 per share as a grant or award tied to performance-based restricted stock units originally granted in June 2023. On June 8, 2026, 28,390 shares were disposed of at $4.62 per share to satisfy tax withholding obligations related to the vesting of 78,750 restricted shares, leaving him with 73,976 directly held shares.
Acacia Research Corp Chief Executive Officer equity award and tax withholding are reported in this Form 4. On June 5, 2026, Martin D. McNulty Jr. acquired 539,160 shares of ACTG common stock at $0.00 per share as a grant or award, increasing his direct holdings to 705,563 shares.
The award relates to performance-based restricted stock units granted on June 7, 2023, tied to the company’s compound annual growth rate of adjusted book value per share. On June 8, 2026, 287,133 shares were disposed of at $4.62 per share solely to satisfy tax withholding obligations for the vesting of 568,303 shares of restricted stock on June 7, 2026. After this tax-withholding disposition, the CEO directly holds 418,430 shares of ACTG common stock.
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received a stock grant as compensation. On March 31, 2026, he was awarded 6,237 shares of common stock at $4.81 per share in lieu of cash for his Q1 2026 director fees. After this grant, he directly holds 174,476 shares of Acacia Research common stock. This is a compensatory share award, not an open-market purchase or sale.
ACACIA RESEARCH CORP director Ajay Sundar acquired 4,158 shares of Common Stock as compensation. The shares were granted on March 31, 2026 in lieu of cash for Q1 2026 director fees at a reference price of $4.81 per share, bringing his direct holdings to 103,430 shares.
Acacia Research Corp General Counsel Jason W. Soncini reported a tax-related share withholding, not an open-market sale. On the transaction date, 6,147 shares of ACTG common stock were withheld to cover tax obligations tied to the vesting of 15,252 restricted shares on March 21, 2026.
After this tax-withholding disposition, Soncini directly owns 191,551 shares of Acacia Research common stock. The event reflects routine equity compensation and associated tax treatment rather than discretionary buying or selling in the market.
Acacia Research Corp Chief Executive Officer Martin D. McNulty Jr. reported a tax-withholding disposition of 8,207 shares of ACTG Common Stock on March 10, 2026. These shares were withheld to satisfy tax obligations tied to the vesting of 20,000 restricted shares on the same date.
After this withholding, McNulty directly owned 166,403 shares of Acacia Research Corp common stock. This transaction reflects a compensation-related tax payment mechanism rather than an open-market purchase or sale.
Gavin T. Molinelli, a director of Acacia Research Corp (ACTG), received 9,231 shares of the company's common stock on 09/30/2025 as payment in lieu of cash for director fees for Q3 2025. The shares were issued at a price of $3.25 per share. After the grant, Mr. Molinelli beneficially owned 160,218 shares of Acacia Research Corp.
The Form 4 was signed by Mr. Molinelli on 10/01/2025 and reports a routine, non-derivative acquisition of equity tied to director compensation. The filing shows direct ownership and does not report any derivative transactions.